GSK3B and breast carcinoma: However, the PI3K inhibitor reversed the expression levels of EMT markers and modulated the activation of PI3K/AKT/GSK3β pathway (Figures 6G,H), demonstrating that inhibitors targeted PPA1 mediated signaling pathways suppressed breast cancer progression.